Follow Us:
Terlipressin Exporter From India

Terlipressin

Terlipressin is a synthetic vasopressin analogue used mainly for the treatment of hepatorenal syndrome and bleeding oesophageal varices. It belongs to the vasopressin receptor agonist group of drugs. It works by stimulating V1 receptors, causing constriction of blood vessels in the abdominal region and reducing portal blood pressure. This helps control bleeding and improves kidney function in certain patients with advanced liver disease. Terlipressin is usually administered by intravenous injection. Common side effects include abdominal pain, nausea, diarrhoea, headache and pale skin. Serious side effects may include breathing difficulties, reduced blood circulation and heart-related complications. It should be administered only under strict medical supervision.

  • Dosage Form:
  • Dosage Strength:
  • Manufacturer:
  • CAS No.:
  • Status:

Applications of Terlipressin

Terlipressin was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:

is okay

Contraindication of Terlipressin

Availability of Terlipressin

Delivery of Terlipressin

Frequently Asked Questions

The most frequently asked questions focus on import, export, documentations, and regulation for Terlipressin.

The is a pharmaceutical active pharmaceutical ingredient (API) used in manufacturing of Terlipressin.

: Provides active pharmaceutical ingredients (APIs), customized production, and OEM/ODM services with research and technical cooperation across Europe, the USA, and India via Primeera Healthcare.

  • Therapeutic Goods Administration (TGA):
  • US Food and Drug Administration (USFDA):
  • European Medicines Agency (EMA):
  • African Medicines Agency (AMA):
  • National Medical Products Administration (NMPA):
  • Central Drugs Standard Control Organization (CDSCO):

Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Terlipressin, subject to confirmation of its current regulatory status and eligibility for import into India.

Documentation Required for Terlipressin Import

The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.

Import Regulations and dcoumentation for Terlipressin

  • Import Documentation Assistance:
    Support with organising commercial invoices, packing lists, manufacturer details, product specifications, certificates of analysis, and other relevant documents required for regulatory review and customs processing.

  • Regulatory Coordination:
    Assistance with identifying applicable CDSCO requirements, import authorisations, and documentation procedures, subject to the product's regulatory status and the proposed import route.
  • Shipping and Customs Coordination:
    Coordination with relevant logistics providers and customs professionals to organise shipment documentation and facilitate clearance where legally permitted.
  • Compliance Verification:
    Preliminary review of available product and shipment documentation to identify potential regulatory gaps before procurement or dispatch. Import arrangements will proceed only after the applicable permissions and restrictions have been verified.

Customs Clearance and Compliance Handling of Terlipressin Import

Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Terlipressin, subject to confirmation of its current regulatory status and eligibility for import into India.

Export Regulations and dcoumentation for Terlipressin

The export of Terlipressin from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.

Documentation Required for Terlipressin Emport

  • Export Documentation Assistance:
    Assistance with organising commercial invoices, packing lists, manufacturer details, Terlipressin specifications, certificates of analysis, and other supporting documents required for Terlipressin export and customs processing.
  • Regulatory Coordination:
    Support in identifying applicable country specific Terlipressin export requirements, relevant manufacturing and export authorisations, and destination-country registration or import approval requirements, subject to the Terlipressin regulatory status.
  • Shipping and Customs Coordination:
    Coordination with logistics providers, freight forwarders, and customs professionals to organise shipping documentation, export declarations, and customs clearance procedures where legally permitted.
  • Compliance Verification:
    Preliminary review of available Terlipressin documentation, labelling, Terlipressin manufacturing information, and destination-market requirements to identify potential regulatory gaps before dispatch. Export arrangements will proceed only after the applicable restrictions and authorisations have been verified.

Customs Clearance and Compliance Handling of Terlipressin Export

Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Terlipressin, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.

Product Export Support

If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.

Email Us

info@primeerahealthcare.com

Call Us

+(123) 456 789 00

Follow Us

Primeera Healthcare

Disclaimer

All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.